Common Contracts
4 similar Irb Authorization Agreement contracts
IRB Authorization AgreementIrb Authorization Agreement • August 11th, 2022
This Institutional Review Board (IRB) authorization agreement is intended to document a formal agreement between the Centers for Disease Control and Prevention (CDC) and an institution that relies on the CDC IRB for review of the activities specified below. This agreement is permitted by the Food and Drug Administration (FDA) regulations governing the protection of human subjects, IRBs, and the conduct of clinical investigations at 21 CFR parts 50, 56, and 312.
IRB Authorization AgreementIrb Authorization Agreement • January 14th, 2019
This Institutional Review Board (IRB) authorization agreement is intended to document a formal agreement between the Centers for Disease Control and Prevention (CDC) and an institution that relies on the CDC IRB for review of the activities specified below. This agreement is permitted by the Food and Drug Administration (FDA) regulations governing the protection of human subjects, IRBs, and the conduct of clinical investigations at 21 CFR parts 50, 56, and 312.
IRB Authorization AgreementIrb Authorization Agreement • January 14th, 2019
This Institutional Review Board (IRB) authorization agreement is intended to document a formal agreement between the Centers for Disease Control and Prevention (CDC) and an institution that relies on the CDC IRB for review of the activities specified below. This agreement is permitted by the Food and Drug Administration (FDA) regulations governing the protection of human subjects, IRBs, and the conduct of clinical investigations at 21 CFR parts 50, 56, and 312.
IRB Authorization AgreementIrb Authorization Agreement • January 14th, 2019
This Institutional Review Board (IRB) authorization agreement is intended to document a formal agreement between the Centers for Disease Control and Prevention (CDC) and an institution that relies on the CDC IRB for review of the activities specified below. This agreement is permitted by the Food and Drug Administration (FDA) regulations governing the protection of human subjects, IRBs, and the conduct of clinical investigations at 21 CFR parts 50, 56, and 312.
